Pre-Vascularized 3-Dimensional Skin Substitutes Promote Angiogenesis and Tissue Repair in a Murine Model of Refractory Skin Ulcers
Source abstract
Abstract
Restoring blood flow is crucial for treating refractory ulcers. Despite advancements in various biomaterials, none incorporating pre-formed blood vessels have been commercialized. To address this, we developed a pre-vascularized three-dimensional (3D) skin substitute (PV-3D skin) designed to enhance healing when treating refractory ulcers. This study aimed to evaluate the therapeutic role of PV-3D skin transplantation in refractory ulcer models, induced by applying mitomycin C to wounds in severe immunodeficient mice. The wounds were then treated with PV-3D skin, non-vascularized 3D skin, skin grafts, or wound dressings. The PV-3D skin group demonstrated healing dynamics comparable to those of the skin graft group, with similar tissue morphology and wound temperature changes. Furthermore, at day 7 post-transplantation, the PV-3D skin group demonstrated significantly higher hypoxia-inducible factor 1-alpha expression levels compared to the 3D skin group. By day 14, the PV-3D skin group exhibited a significantly larger vascular area compared to the 3D skin group. Notably, PV-3D skin treatment stimulated host-derived angiogenesis, thereby enhancing wound healing and reducing the recurrence of refractory ulcers. These results suggest that PV-3D skin transplantation offers a promising therapeutic approach for refractory ulcers, especially in terms of angiogenesis.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Wound Healing and Treatments · Tissue Engineering and Regenerative Medicine · 3D Printing in Biomedical Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Plastic and Reconstructive Surgery, National Defense Medical College, Saitama 359-8513, Japan
Division of Biomedical Engineering, National Defense Medical College Research Institute, Saitama 359-8513, Japan
Division of Bioinformation and Therapeutic Systems, National Defense Medical College Research Institute, Saitama 359-8513, Japan
Funding
JSPS KAKENHI
References (49)
Show source-provided references
1. A randomized controlled trial of larval therapy for the debridement of leg ulcers: Results of a multicenter, randomized, controlled, open, observer blind, parallel group study10.1111/wrr.12127 ↗
2. Frequency of debridements and time to heal: A retrospective cohort study of 312 744 wounds10.1001/jamadermatol.2013.4960 ↗
3. Banakh, I., Cheshire, P., Rahman, M., Carmichael, I., Jagadeesan, P., Cameron, N.R., Cleland, H., and Akbarzadeh, S. (2020). A Comparative Study of Engineered Dermal Templates for Skin Wound Repair in a Mouse Model. Int. J. Mol. Sci., 21.10.3390/ijms21124508 ↗
4. Fu, H., Zhang, D., Zeng, J., Fu, Q., Chen, Z., Sun, X., Yang, Y., Li, S., and Chen, M. (2023). Application of 3D-printed tissue-engineered skin substitute using innovative biomaterial loaded with human adipose-derived stem cells in wound healing. Int. J. Bioprint, 9.10.18063/ijb.v9i2.674 ↗
5. Randomized comparison of OASIS wound matrix versus moist wound dressing in the treatment of difficult-to-heal wounds of mixed arterial/venous etiology10.1097/01.ASW.0000363485.17224.26 ↗
6. Burgess, J.L., Wyant, W.A., Abdo Abujamra, B., Kirsner, R.S., and Jozic, I. (2021). Diabetic Wound-Healing Science. Medicina, 57.10.3390/medicina57101072 ↗
7. Okonkwo, U.A., and DiPietro, L.A. (2017). Diabetes and Wound Angiogenesis. Int. J. Mol. Sci., 18.10.3390/ijms18071419 ↗
8. Disturbed hypoxic responses as a pathogenic mechanism of diabetic foot ulcers10.1002/dmrr.2742 ↗
9. Wound healing and treating wounds: Chronic wound care and management10.1016/j.jaad.2015.08.070 ↗
10. Miyazaki, H., Tsunoi, Y., Akagi, T., Sato, S., Akashi, M., and Saitoh, D. (2019). A novel strategy to engineer pre-vascularized 3-dimensional skin substitutes to achieve efficient, functional engraftment. Sci. Rep., 9.10.1038/s41598-019-44113-6 ↗
11. Fabrication of cellular multilayers with nanometer-sized extracellular matrix films10.1002/anie.200701089 ↗
12. Nagano, H., Suematsu, Y., Takuma, M., Aoki, S., Satoh, A., Takayama, E., Kinoshita, M., Morimoto, Y., Takeoka, S., and Fujie, T. (2021). Enhanced cellular engraftment of adipose-derived mesenchymal stem cell spheroids by using nanosheets as scaffolds. Sci. Rep., 11.10.1038/s41598-021-93642-6 ↗
13. Quantitative evaluation of skin barrier function using water evaporation time related to transepidermal water loss10.1111/srt.13242 ↗
14. Skin wound healing determined by water loss10.1016/0022-4804(85)90035-6 ↗
15. Skin graft monitoring using forward-looking infrared thermal imaging10.1111/iwj.70107 ↗
16. Skin microdialysis coupled with laser speckle contrast imaging to assess microvascular reactivity10.1016/j.mvr.2011.09.009 ↗
17. Applications of Laser Speckle Contrast Imaging Technology in Dermatology10.1016/j.xjidi.2023.100187 ↗
18. Assessment of skin microvascular function and dysfunction with laser speckle contrast imaging10.1161/CIRCIMAGING.111.970418 ↗
19. Laser speckle contrast imaging accurately measures blood flow over moving skin surfaces10.1016/j.mvr.2010.11.013 ↗
20. The role of fibroblast activation protein in health and malignancy10.1007/s10555-020-09909-3 ↗
21. Enhanced healing of mitomycin C-treated wounds in rats using inbred adipose tissue-derived stromal cells within an atelocollagen matrix10.1111/j.1524-475X.2007.00258.x ↗
22. The effects of intradermal and topical mitomycin C on wound healing10.1016/j.otohns.2006.02.024 ↗
23. Study of wound healing in rats treated with topical and injected mitomycin C10.1177/000348940811701015 ↗
24. Enhanced healing of mitomycin C-treated healing-impaired wounds in rats with PRP-containing fragmin/protamine microparticles (PRP&F/P MPs)10.3109/2000656X.2015.1034723 ↗
25. The effect of platelet-rich fibrin on normal dermal fibroblast proliferation after mitomycin-c treatment: An in vitro study10.1016/j.amsu.2021.01.093 ↗
26. Mitomycin C: A clinical update10.1053/ctrv.2000.0202 ↗
27. Persistent DNA damage caused by low levels of mitomycin C induces irreversible cell senescence10.4161/cc.21506 ↗
28. Effect of mitomycin on normal dermal fibroblast and HaCat cell: An in vitro study10.1631/jzus.B1200055 ↗
29. Frueh, F.S., Spater, T., Korbel, C., Scheuer, C., Simson, A.C., Lindenblatt, N., Giovanoli, P., Menger, M.D., and Laschke, M.W. (2018). Prevascularization of dermal substitutes with adipose tissue-derived microvascular fragments enhances early skin grafting. Sci. Rep., 8.10.1038/s41598-018-29252-6 ↗
30. Cooperation of endothelial and smooth muscle cells derived from human induced pluripotent stem cells enhances neovascularization in dermal wounds10.1089/ten.tea.2012.0768 ↗
31. Endothelial cells derived from human iPSCS increase capillary density and improve perfusion in a mouse model of peripheral arterial disease10.1161/ATVBAHA.111.230938 ↗
32. Tissue Engineering-Based Strategies for Diabetic Foot Ulcer Management10.1089/wound.2021.0081 ↗
33. Comparative Effectiveness of a Bioengineered Living Cellular Construct and Cryopreserved Cadaveric Skin Allograft for the Treatment of Venous Leg Ulcers in a Real-World Setting10.1089/wound.2017.0738 ↗
34. A bioengineered living cell construct activates an acute wound healing response in venous leg ulcers10.1126/scitranslmed.aaf8611 ↗
35. A bioengineered living cell construct activates metallothionein/zinc/MMP8 and inhibits TGFβ to stimulate remodeling of fibrotic venous leg ulcers10.1111/wrr.12778 ↗
36. The Role of Hypoxia-Inducible Factor in Wound Healing10.1089/wound.2013.0520 ↗
37. Sustained expression of Hif-1alpha in the diabetic environment promotes angiogenesis and cutaneous wound repair10.1111/j.1524-475X.2007.00278.x ↗
38. Stabilization of HIF-1alpha is critical to improve wound healing in diabetic mice10.1073/pnas.0805230105 ↗
39. HIF-1 expression in healing wounds: HIF-1alpha induction in primary inflammatory cells by TNF-alpha10.1152/ajpcell.2001.281.6.C1971 ↗
40. Chronic skin ulcers
41. Cellular and molecular composition of human skin in long-term xenografts on SCID mice10.1111/j.1600-0625.1993.tb00035.x ↗
42. Long-term maintenance of skin immune system in a NOD-Scid IL2rγ(null) mouse model transplanted with human skin10.1111/exd.12530 ↗
43. Macrophage activation and innate resistance to infection in SCID mice10.1016/S0171-2985(11)80448-1 ↗
44. Jimi, S., Kimura, M., De Francesco, F., Riccio, M., Hara, S., and Ohjimi, H. (2017). Acceleration Mechanisms of Skin Wound Healing by Autologous Micrograft in Mice. Int. J. Mol. Sci., 18.10.3390/ijms18081675 ↗
45. Kim, S.W., Zhang, H.Z., Guo, L., Kim, J.M., and Kim, M.H. (2012). Amniotic mesenchymal stem cells enhance wound healing in diabetic NOD/SCID mice through high angiogenic and engraftment capabilities. PLoS ONE, 7.10.1371/annotation/f6ebe3d3-ef7c-42ce-86fe-d5a661d7f67f ↗
46. Evolution of ischemia and neovascularization in a murine model of full thickness human wound healing10.1111/wrr.12847 ↗
47. A small molecule HIF-1α stabilizer that accelerates diabetic wound healing10.1038/s41467-021-23448-7 ↗
48. A Bilayer Engineered Skin Substitute for Wound Repair in an Irradiation-Impeded Healing Model on Rat10.1089/wound.2014.0551 ↗
49. Autologous blood transfusion stimulates wound healing in diabetic mice through activation of the HIF-1α pathway by improving the blood preservation solution10.1096/fj.201900324RRR ↗